lantibiotic-based recombinant protein (Novacta)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelantibiotic-based recombinant protein (Novacta)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovacta Biosystems Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacta Biosystems LtdCantab Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A